Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 199 participants.
Also called NCT07078071
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; single masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 199 participants
- Sponsor
- Huawei Device Co., Ltd
- Registry
-
NCT07078071
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT07078071. Non-randomized; single masking; primary purpose diagnostic. Start 2022-10-18 (actual); primary completion 2023-03-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software
- Condition
- Arrhythmia, Heart
- Intervention (Device)
- ECG (electrocardiogram)
- Lead sponsor
- Huawei Device Co., Ltd
Record details
- Record id
cardio:ct-nct07078071- Content hash
81c4a9a53f4dc799c5a216bf5df0e79fdca80502ab181b73b682f016343e22e4